Association Between Overactive Bladder and Polyneuropathy in Diabetic Patients
Nermin Tanik, Serhat Tanik, Sebahattin Albayrak, K├╝rsat Zengin, Levent Ertugrul Inan, Emel Kiyak Caglayan, Asuman Celikbilek, Kadir Kirboga, Mesut Gurdal
Int Neurourol J. 2016;20(3):232-239.   Published online 2016 Sep 23
DOI: https://doi.org/10.5213/inj.1632508.254
Citations to this article as recorded by
  Crossref logo
The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A
Chung-Cheng Wang, Yung-Hong Jiang, Hann-Chorng Kuo
Toxins.2020; 12(3): 186.     CrossRef
Physiopathology of the diabetic bladder
Tatiana Bolgeo, Antonio Maconi, Marinella Bertolotti, Annalisa Roveta, Marta Betti, Denise Gatti, Carmelo Boccafoschi
Archivio Italiano di Urologia e Andrologia.2020;[Epub]     CrossRef
NLRP3 Promotes Diabetic Bladder Dysfunction and Changes in Symptom-Specific Bladder Innervation
Francis M. Hughes, Nathan A. Hirshman, Brian M. Inouye, Huixia Jin, Eloise W. Stanton, Chloe E. Yun, Leah G. Davis, Jonathan C. Routh, J. Todd Purves
Diabetes.2019; 68(2): 430.     CrossRef
Overactive bladder in therapeutic practice: its association with cardiometabolic disorders
G. G. Sharvadze, B. U. Mardanov, R. A. Yandieva, M. N. Mamedov
Profilakticheskaya meditsina.2018; 21(6): 124.     CrossRef
The Beneficial Effect of Fesoterodine, a Competitive Muscarinic Receptor Antagonist on Erectile Dysfunction in Streptozotocin-induced Diabetic Rats
Didem Yilmaz-Oral, Nur Bayatli, Serap Gur
Urology.2017; 107: 271.e1.     CrossRef